DK1069902T3 - Anvendelse af phospholipider til fremstilling af et lægemiddel til forebyggelse af adhæsioner - Google Patents
Anvendelse af phospholipider til fremstilling af et lægemiddel til forebyggelse af adhæsionerInfo
- Publication number
- DK1069902T3 DK1069902T3 DK98955792T DK98955792T DK1069902T3 DK 1069902 T3 DK1069902 T3 DK 1069902T3 DK 98955792 T DK98955792 T DK 98955792T DK 98955792 T DK98955792 T DK 98955792T DK 1069902 T3 DK1069902 T3 DK 1069902T3
- Authority
- DK
- Denmark
- Prior art keywords
- adhesions
- phospholipids
- drug
- prevention
- manufacture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9807298.6A GB9807298D0 (en) | 1998-04-03 | 1998-04-03 | Medicament |
PCT/GB1998/003540 WO1999051244A1 (en) | 1998-04-03 | 1998-11-26 | Use of phospholipids for the manufacture of a medicament for the prevention of adhesions |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1069902T3 true DK1069902T3 (da) | 2004-06-07 |
Family
ID=10829890
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98955792T DK1069902T3 (da) | 1998-04-03 | 1998-11-26 | Anvendelse af phospholipider til fremstilling af et lægemiddel til forebyggelse af adhæsioner |
Country Status (12)
Country | Link |
---|---|
US (1) | US6719960B1 (bg) |
EP (1) | EP1069902B1 (bg) |
JP (1) | JP4287050B2 (bg) |
AT (1) | ATE259234T1 (bg) |
AU (1) | AU1251799A (bg) |
CA (1) | CA2327693C (bg) |
DE (1) | DE69821655T2 (bg) |
DK (1) | DK1069902T3 (bg) |
ES (1) | ES2214748T3 (bg) |
GB (2) | GB9807298D0 (bg) |
PT (1) | PT1069902E (bg) |
WO (1) | WO1999051244A1 (bg) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9807298D0 (en) | 1998-04-03 | 1998-06-03 | Britannia Pharmaceuticals Ltd | Medicament |
US6156294A (en) * | 1999-11-28 | 2000-12-05 | Scientific Development And Research, Inc. | Composition and method for treatment of otitis media |
GB0007150D0 (en) * | 2000-03-24 | 2000-05-17 | Lamellar Therapeutics Limited | Immunotherapeutic methods and compositions |
WO2002094283A2 (en) * | 2001-05-21 | 2002-11-28 | Britannia Pharmaceuticals Limited | Use of phospholipids in the treatment of degenerative lung disease such as copd or cystic fibrosis and to enhance delivery of drugs |
GB0115505D0 (en) * | 2001-06-25 | 2001-08-15 | Britannia Pharmaceuticals Ltd | Prevention of surgical adhesions |
GB0200704D0 (en) * | 2002-01-14 | 2002-02-27 | Britannia Pharmaceuticals Ltd | Use of phospholipids in peritoneal dialysis |
GB0207653D0 (en) * | 2002-04-03 | 2002-05-15 | Lamellar Therapeutics Ltd | Methods of using lamellar bodies for therapeutic purposes |
EP1426053A1 (en) * | 2002-12-03 | 2004-06-09 | Fresenius Kabi Deutschland GmbH | Use of amphiphilic lipids for reducing tumor metastasis |
GB0322448D0 (en) | 2003-09-25 | 2003-10-29 | Lamellar Therapeutics Ltd | Using lamellar bodies to modify linear biological macro molecules |
US7704223B2 (en) | 2003-10-07 | 2010-04-27 | Northgate Technologies Inc. | System and method for delivering a substance to a body cavity |
EP1680173B1 (en) * | 2003-10-31 | 2011-01-12 | Trudell Medical International | System for manipulating a catheter for delivering a substance to a body cavity |
GB0426010D0 (en) * | 2004-11-26 | 2004-12-29 | Britannia Pharmaceuticals Ltd | Improvements in or relating to organic materials |
US9119901B2 (en) | 2005-04-28 | 2015-09-01 | Warsaw Orthopedic, Inc. | Surface treatments for promoting selective tissue attachment to medical impants |
US8414907B2 (en) | 2005-04-28 | 2013-04-09 | Warsaw Orthopedic, Inc. | Coatings on medical implants to guide soft tissue healing |
US8663271B2 (en) | 2006-08-04 | 2014-03-04 | Northgate Technologies, Inc. | In-dwelling port for access into a body |
US8020726B1 (en) * | 2006-10-18 | 2011-09-20 | Sandia Corporation | Powder dispersion system |
US20080241270A1 (en) * | 2007-03-30 | 2008-10-02 | Neal Robert A | Fluid composition for inhibiting surgical adhesion formation and related method of production |
US9572595B1 (en) | 2014-03-05 | 2017-02-21 | Northgate Technologies Inc. | In-dwelling port for access into a body |
GB201511058D0 (en) * | 2015-06-23 | 2015-08-05 | Lamellar Biomedical Ltd | Compositions and methods for using lamellar bodies for therapeutic purposes |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58164513A (ja) * | 1982-03-25 | 1983-09-29 | Teijin Ltd | 肺表面活性物質及びその調製法 |
DE3229179C2 (de) * | 1982-08-05 | 1986-04-17 | A. Nattermann & Cie GmbH, 5000 Köln | Lungensurfactant |
GB8613811D0 (en) * | 1986-06-06 | 1986-07-09 | Phares Pharm Res Nv | Composition & method |
IN166447B (bg) * | 1985-11-27 | 1990-05-12 | Ethicon Inc | |
WO1991012026A1 (en) | 1990-02-14 | 1991-08-22 | Macnaught Pty Limited | Means of reducing surgical adhesions |
AU660612B2 (en) | 1990-05-18 | 1995-07-06 | Mitsubishi-Tokyo Pharmaceuticals, Inc. | Remedy for asthma |
US5438044A (en) * | 1992-06-30 | 1995-08-01 | Rhone-Poulenc Rorer | Phospholipid composition |
AU7685798A (en) * | 1997-05-29 | 1998-12-30 | Applied Biotechnologies Inc. | Compositions and methods for preventing adhesion |
GB9807298D0 (en) | 1998-04-03 | 1998-06-03 | Britannia Pharmaceuticals Ltd | Medicament |
-
1998
- 1998-04-03 GB GBGB9807298.6A patent/GB9807298D0/en not_active Ceased
- 1998-11-26 JP JP2000542015A patent/JP4287050B2/ja not_active Expired - Fee Related
- 1998-11-26 CA CA002327693A patent/CA2327693C/en not_active Expired - Fee Related
- 1998-11-26 US US09/582,286 patent/US6719960B1/en not_active Expired - Fee Related
- 1998-11-26 WO PCT/GB1998/003540 patent/WO1999051244A1/en active IP Right Grant
- 1998-11-26 EP EP98955792A patent/EP1069902B1/en not_active Expired - Lifetime
- 1998-11-26 AU AU12517/99A patent/AU1251799A/en not_active Abandoned
- 1998-11-26 GB GB9825971A patent/GB2335853A/en not_active Withdrawn
- 1998-11-26 PT PT98955792T patent/PT1069902E/pt unknown
- 1998-11-26 ES ES98955792T patent/ES2214748T3/es not_active Expired - Lifetime
- 1998-11-26 DK DK98955792T patent/DK1069902T3/da active
- 1998-11-26 AT AT98955792T patent/ATE259234T1/de active
- 1998-11-26 DE DE69821655T patent/DE69821655T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US6719960B1 (en) | 2004-04-13 |
WO1999051244A1 (en) | 1999-10-14 |
GB2335853A (en) | 1999-10-06 |
ES2214748T3 (es) | 2004-09-16 |
GB9807298D0 (en) | 1998-06-03 |
CA2327693C (en) | 2006-11-21 |
AU1251799A (en) | 1999-10-25 |
DE69821655D1 (de) | 2004-03-18 |
PT1069902E (pt) | 2004-06-30 |
ATE259234T1 (de) | 2004-02-15 |
EP1069902B1 (en) | 2004-02-11 |
GB9825971D0 (en) | 1999-01-20 |
CA2327693A1 (en) | 1999-10-14 |
DE69821655T2 (de) | 2004-12-23 |
JP2002510638A (ja) | 2002-04-09 |
EP1069902A1 (en) | 2001-01-24 |
JP4287050B2 (ja) | 2009-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1069902T3 (da) | Anvendelse af phospholipider til fremstilling af et lægemiddel til forebyggelse af adhæsioner | |
BR0205722A (pt) | Formulação de liberação prolongada e método para o tratamento de um paciente que sofre de dor | |
IL195723A (en) | Use of p53 inhibitors for the preparation of medicament | |
DE69931159D1 (de) | Antimikrobielle zusammensetzungen enthaltend taurolidin, zitronensäure und natriumzitrat | |
BR9911071A (pt) | Preparações para aplicação de agentes antiinflamatórios, especialmente anti-sépticos e/ou agentes promotores da cura de feridas no trato respiratório superior e/ou no ouvido | |
DE60143889D1 (de) | Parasiticide formulierung und methode zur herstellung dieser formulierung | |
BR0112054A (pt) | Composição formadora de micelas, e métodos para a administração e a proteção de um agente terapêutico | |
DE60121992D1 (de) | Zusammensetzung zur verabreichung und beschichtung medizinischer geräte | |
BRPI9908182B8 (pt) | composições de proteína de matriz para cura de feridas | |
DK0680326T3 (da) | Farmaceutisk formulering af nikotinafhængighed. | |
EE04997B1 (et) | Loteprednooli ja antihistamiinseid aineid sisaldav farmatseutiline kompositsioon, neid aineid sisaldav ravim, meetod selle ravimi valmistamiseks ja nende ainete kombinatsiooni kasutamine | |
SE9704644D0 (sv) | New use | |
ATE220547T1 (de) | Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung | |
ATE464878T1 (de) | Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl | |
EA200000176A1 (ru) | Применение физиологически приемлемых соединений, солей и комплексов ванадия | |
HUP0000873A2 (hu) | A levobupivakain arcsebészeti alkalmazása | |
TR199701121T1 (xx) | Benazepril veya benazeprilat ve valsartan i�eren kombinasyon bile�imleri. | |
DE69426530D1 (de) | Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz | |
BR9913982A (pt) | Derivado de piridil-4h-1,2,4-oxadiazina opticamente ativo e seu uso no tratamento de doenças vasculares | |
ID27083A (id) | Komposisi farmasi untuk pencegahan dan pengobatan penyakit-penyakit yang behubungan dengan sitopati jaringan okuler fundus | |
SE9902597D0 (sv) | New use | |
BR9809351A (pt) | Tecido de bainha dérmica na cura de lesões | |
GEP20043231B (en) | Resorcinol Composition | |
ATE280575T1 (de) | Transdermales therapeutisches system zur anwendung von candesartan | |
AR011707A1 (es) | Composicion farmaceutica que comprende tirosina y un alergeno opcionalmente modificado, procedimiento para su preparacion y el uso de la misma para la manufactura de un medicamento. |